RPRX
insider transactionsRoyalty Pharma plc — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
-1.4M
0 buy · 1.4M sell
Net value · 365d
-$57.8M
$0 in · $57.8M out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
54
0 buy · 1.4M sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Sell·S
EVP & CFO · 10b5-1
$93.3K
1.9K sh · $49.78
Own -4%
-
Sell·S
EVP & CFO · 10b5-1
$1.6M
32.9K sh · $49.78
Own -100%
-
Grant·A
Director
$37.5K
815 sh · $45.98
Own +1%
-
Sell·S
EVP & CFO · 10b5-1
$85.4K
1.9K sh · $45.53
Own -4%
-
Sell·S
EVP & CFO · 10b5-1
$1.5M
32.9K sh · $45.53
Own -33%
-
Sell·S
EVP & CFO · 10b5-1
$27.4K
583 sh · $47.01
Own -1%
-
Sell·S
EVP & CFO · 10b5-1
$1.0M
22.5K sh · $46.67
Own -17%
-
Sell·S
EVP & CFO · 10b5-1
$490.3K
10.4K sh · $47.01
Own -10%
-
Sell·S
EVP & CFO · 10b5-1
$60.3K
1.3K sh · $46.67
Own -3%
-
Sell·S
EVP & CFO · 10b5-1
$85.0K
1.9K sh · $45.32
Own -4%
-
Sell·S
EVP & CFO · 10b5-1
$1.5M
32.9K sh · $45.32
Own -20%
-
Grant·A
EVP, Research & Investments
$0
20.0K sh
Own +270%
-
Grant·A
Hite Christopher KEY
EVP & Vice Chairman
$0
26.6K sh
Own +4%
-
Grant·A
CEO, Chairman of the Board
$0
157.8K sh
Own +17%
-
Grant·A
EVP & CFO
$0
26.6K sh
Own +116%
-
Sell·S
EVP & CFO · 10b5-1
$825.8K
19.1K sh · $43.29
Own -10%
-
Sell·S
EVP & CFO · 10b5-1
$47.1K
1.1K sh · $43.29
Own -5%
-
Sell·S
EVP & CFO · 10b5-1
$4.7M
108.8K sh · $42.84
Own -37%
-
Sell·S
EVP & CFO · 10b5-1
$265.4K
6.2K sh · $42.84
Own -21%
-
Sell·S
EVP & CFO · 10b5-1
$4.3M
102.6K sh · $42.08
Own -26%
-
Sell·S
EVP & CFO · 10b5-1
$245.9K
5.8K sh · $42.08
Own -16%
-
Sell·S
EVP, Research & Investments · 10b5-1
$821.8K
20.0K sh · $41.09
Own -100%
-
Sell·S
EVP, Research & Investments · 10b5-1
$805.2K
20.0K sh · $40.26
Own -50%
-
Sell·S
EVP & CFO · 10b5-1
$147.6K
3.8K sh · $39.35
Own -9%
-
Sell·S
EVP & CFO · 10b5-1
$2.6M
65.8K sh · $39.35
Own -14%
-
Sell·S
EVP, Research & Investments · 10b5-1
$790.4K
20.0K sh · $39.52
Own -33%
-
Sell·S
EVP, Research & Investments · 10b5-1
$815.6K
20.0K sh · $40.78
Own -25%
-
Sell·S
EVP, Research & Investments · 10b5-1
$769.6K
20.0K sh · $38.48
Own -20%
-
Sell·S
EVP & CFO · 10b5-1
$2.5M
65.8K sh · $38.42
Own -12%
-
Sell·S
EVP & CFO · 10b5-1
$144.1K
3.8K sh · $38.42
Own -9%
-
Grant·A
Director
$37.5K
967 sh · $38.74
Own +1%
-
Sell·S
EVP, Research & Investments · 10b5-1
$786.4K
20.0K sh · $39.32
Own -17%
-
Sell·S
EVP, Research & Investments · 10b5-1
$767.6K
20.0K sh · $38.38
Own -14%
-
Sell·S
EVP, Investments & CLO · 10b5-1
$1.2M
30.7K sh · $38.50
Own -100%
-
Sell·S
EVP, Investments & CLO · 10b5-1
$3.1M
79.3K sh · $38.57
Own -72%
-
Sell·S
EVP, Research & Investments · 10b5-1
$766.4K
20.0K sh · $38.32
Own -12%
-
Sell·S
EVP & CFO · 10b5-1
$2.5M
65.8K sh · $38.36
Own -11%
-
Sell·S
EVP & CFO · 10b5-1
$143.8K
3.8K sh · $38.36
Own -8%
-
Sell·S
EVP, Research & Investments · 10b5-1
$714.2K
18.2K sh · $39.15
Own -71%
-
Sell·S
EVP, Research & Investments · 10b5-1
$913.5K
23.3K sh · $39.15
Own -13%
-
Sell·S
EVP, Investments & CLO · 10b5-1
$4.4M
110.0K sh · $39.77
Own -50%
-
Sell·S
EVP, Research & Investments · 10b5-1
$931.7K
23.3K sh · $39.93
Own -11%
-
Sell·S
EVP, Research & Investments · 10b5-1
$727.9K
18.2K sh · $39.90
Own -42%
-
Sell·S
EVP & CFO · 10b5-1
$2.6M
65.8K sh · $39.87
Own -10%
-
Sell·S
EVP & CFO · 10b5-1
$149.5K
3.8K sh · $39.87
Own -7%
-
Sell·S
EVP & CFO · 10b5-1
$405.6K
10.7K sh · $37.96
Own -2%
-
Sell·S
EVP & CFO · 10b5-1
$120.9K
3.1K sh · $38.67
Own -6%
-
Sell·S
EVP & CFO · 10b5-1
$23.7K
624 sh · $37.96
Own -1%
-
Sell·S
EVP & CFO · 10b5-1
$2.1M
55.1K sh · $38.67
Own -8%
-
Sell·S
EVP, Investments & CLO · 10b5-1
$106.1K
2.8K sh · $38.29
Own -92%
-
Sell·S
EVP, Investments & CLO · 10b5-1
$96.4K
2.5K sh · $39.01
Own -100%
-
Sell·S
EVP, Investments & CLO · 10b5-1
$977.3K
25.5K sh · $38.28
Own -91%
-
Sell·S
EVP, Investments & CLO · 10b5-1
$1.8M
47.4K sh · $38.28
Own -91%
-
Sell·S
EVP, Investments & CLO · 10b5-1
$180.5K
4.6K sh · $39.01
Own -43%
-
Sell·S
EVP, Investments & CLO · 10b5-1
$1.8M
47.8K sh · $38.28
Own -82%
-
Sell·S
EVP, Investments & CLO · 10b5-1
$9.0K
230 sh · $39.03
Own -100%
-
Sell·S
EVP, Investments & CLO · 10b5-1
$179.4K
4.6K sh · $39.01
Own -100%
-
Sell·S
EVP & CFO · 10b5-1
$147.4K
3.8K sh · $39.30
Own -6%
-
Sell·S
EVP & CFO · 10b5-1
$2.6M
65.8K sh · $39.30
Own -8%
-
Exercise·C
EVP, Research & Investments
$0
16.0K sh
Own +7%
-
Exercise·C
EVP, Research & Investments
$0
160.0K sh
Own +343%
-
Grant·A
Hite Christopher KEY
EVP & Vice Chairman
$0
6.2K sh
Own +1%
-
Grant·A
EVP, Research & Investments
$0
4.6K sh
Own +12%
-
Grant·A
EVP, Investments & CLO
$0
6.2K sh
Own +12%
-
Grant·A
CEO, Chairman of the Board
$0
36.6K sh
Own +4%
-
Grant·A
EVP & CFO
$0
6.2K sh
Own +12%
-
Grant·A
Director
$37.5K
1.0K sh · $35.79
Own +1%
-
Sell·S
Director
$1.2M
33.5K sh · $36.23
Own -15%
-
Other·G
EVP & CFO
$0
1.0K sh
Own -2%
-
Other·G
EVP, Research & Investments
$0
3.0K sh
Own -1%
-
Other·G
EVP, Investments & CLO
$0
8.5K sh
Own -100%
-
Other·G
CEO, Chairman of the Board
$0
60.0K sh
Own -8%
-
Exercise·C
Director
$0
14.5K sh
Own New
-
Exercise·C
Director
$0
144.7K sh
Own +173%
-
Grant·A
Hite Christopher KEY
EVP & Vice Chairman
$0
3.7K sh
Own +1%
-
Grant·A
EVP & CFO
$0
3.7K sh
Own +8%
-
Grant·A
EVP, Research & Investments
$0
2.8K sh
Own +8%
-
Grant·A
EVP, Investments & CLO
$0
3.7K sh
Own +8%
-
Grant·A
CEO, Chairman of the Board
$0
21.9K sh
Own +2%
-
Grant·A
Director
$0
2.8K sh
Own New
-
Grant·A
Director
$0
5.8K sh
Own +211%
-
Grant·A
Director
$0
2.8K sh
Own New
-
Grant·A
Director
$0
5.8K sh
Own +211%
-
Grant·A
Director
$37.5K
1.1K sh · $35.24
Own +2%
-
Grant·A
Director
$37.5K
1.1K sh · $35.24
Own +2%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Apr 28, 2026 | Coyne Terrance P. KEY 10b5-1 | Sell S | 1.9K | $93.3K |
| Apr 28, 2026 | Coyne Terrance P. KEY 10b5-1 | Sell S | 32.9K | $1.6M |
| Mar 31, 2026 | Bassler Bonnie L | Grant A | 815 | $37.5K |
| Mar 23, 2026 | Coyne Terrance P. KEY 10b5-1 | Sell S | 1.9K | $85.4K |
| Mar 23, 2026 | Coyne Terrance P. KEY 10b5-1 | Sell S | 32.9K | $1.5M |
| Mar 2, 2026 | Coyne Terrance P. KEY 10b5-1 | Sell S | 583 | $27.4K |
| Mar 2, 2026 | Coyne Terrance P. KEY 10b5-1 | Sell S | 22.5K | $1.0M |
| Mar 2, 2026 | Coyne Terrance P. KEY 10b5-1 | Sell S | 10.4K | $490.3K |
| Mar 2, 2026 | Coyne Terrance P. KEY 10b5-1 | Sell S | 1.3K | $60.3K |
| Feb 23, 2026 | Coyne Terrance P. KEY 10b5-1 | Sell S | 1.9K | $85.0K |
| Feb 23, 2026 | Coyne Terrance P. KEY 10b5-1 | Sell S | 32.9K | $1.5M |
| Feb 11, 2026 | Urist Marshall | Grant A | 20.0K | $0 |
| Feb 11, 2026 | Hite Christopher KEY | Grant A | 26.6K | $0 |
| Feb 11, 2026 | Legorreta Pablo G. KEY | Grant A | 157.8K | $0 |
| Feb 11, 2026 | Coyne Terrance P. KEY | Grant A | 26.6K | $0 |
| Feb 4, 2026 | Coyne Terrance P. KEY 10b5-1 | Sell S | 19.1K | $825.8K |
| Feb 4, 2026 | Coyne Terrance P. KEY 10b5-1 | Sell S | 1.1K | $47.1K |
| Feb 3, 2026 | Coyne Terrance P. KEY 10b5-1 | Sell S | 108.8K | $4.7M |
| Feb 3, 2026 | Coyne Terrance P. KEY 10b5-1 | Sell S | 6.2K | $265.4K |
| Feb 2, 2026 | Coyne Terrance P. KEY 10b5-1 | Sell S | 102.6K | $4.3M |
| Feb 2, 2026 | Coyne Terrance P. KEY 10b5-1 | Sell S | 5.8K | $245.9K |
| Jan 30, 2026 | Urist Marshall 10b5-1 | Sell S | 20.0K | $821.8K |
| Jan 23, 2026 | Urist Marshall 10b5-1 | Sell S | 20.0K | $805.2K |
| Jan 20, 2026 | Coyne Terrance P. KEY 10b5-1 | Sell S | 3.8K | $147.6K |
| Jan 20, 2026 | Coyne Terrance P. KEY 10b5-1 | Sell S | 65.8K | $2.6M |
| Jan 16, 2026 | Urist Marshall 10b5-1 | Sell S | 20.0K | $790.4K |
| Jan 9, 2026 | Urist Marshall 10b5-1 | Sell S | 20.0K | $815.6K |
| Jan 2, 2026 | Urist Marshall 10b5-1 | Sell S | 20.0K | $769.6K |
| Jan 2, 2026 | Coyne Terrance P. KEY 10b5-1 | Sell S | 65.8K | $2.5M |
| Jan 2, 2026 | Coyne Terrance P. KEY 10b5-1 | Sell S | 3.8K | $144.1K |
| Dec 31, 2025 | Bassler Bonnie L | Grant A | 967 | $37.5K |
| Dec 26, 2025 | Urist Marshall 10b5-1 | Sell S | 20.0K | $786.4K |
| Dec 19, 2025 | Urist Marshall 10b5-1 | Sell S | 20.0K | $767.6K |
| Dec 18, 2025 | Lloyd George W. 10b5-1 | Sell S | 30.7K | $1.2M |
| Dec 17, 2025 | Lloyd George W. 10b5-1 | Sell S | 79.3K | $3.1M |
| Dec 16, 2025 | Urist Marshall 10b5-1 | Sell S | 20.0K | $766.4K |
| Dec 15, 2025 | Coyne Terrance P. KEY 10b5-1 | Sell S | 65.8K | $2.5M |
| Dec 15, 2025 | Coyne Terrance P. KEY 10b5-1 | Sell S | 3.8K | $143.8K |
| Dec 5, 2025 | Urist Marshall 10b5-1 | Sell S | 18.2K | $714.2K |
| Dec 5, 2025 | Urist Marshall 10b5-1 | Sell S | 23.3K | $913.5K |
| Dec 3, 2025 | Lloyd George W. 10b5-1 | Sell S | 110.0K | $4.4M |
| Dec 1, 2025 | Urist Marshall 10b5-1 | Sell S | 23.3K | $931.7K |
| Dec 1, 2025 | Urist Marshall 10b5-1 | Sell S | 18.2K | $727.9K |
| Dec 1, 2025 | Coyne Terrance P. KEY 10b5-1 | Sell S | 65.8K | $2.6M |
| Dec 1, 2025 | Coyne Terrance P. KEY 10b5-1 | Sell S | 3.8K | $149.5K |
| Nov 24, 2025 | Coyne Terrance P. KEY 10b5-1 | Sell S | 10.7K | $405.6K |
| Nov 24, 2025 | Coyne Terrance P. KEY 10b5-1 | Sell S | 3.1K | $120.9K |
| Nov 24, 2025 | Coyne Terrance P. KEY 10b5-1 | Sell S | 624 | $23.7K |
| Nov 24, 2025 | Coyne Terrance P. KEY 10b5-1 | Sell S | 55.1K | $2.1M |
| Nov 19, 2025 | Lloyd George W. 10b5-1 | Sell S | 2.8K | $106.1K |
| Nov 19, 2025 | Lloyd George W. 10b5-1 | Sell S | 2.5K | $96.4K |
| Nov 19, 2025 | Lloyd George W. 10b5-1 | Sell S | 25.5K | $977.3K |
| Nov 19, 2025 | Lloyd George W. 10b5-1 | Sell S | 47.4K | $1.8M |
| Nov 19, 2025 | Lloyd George W. 10b5-1 | Sell S | 4.6K | $180.5K |
| Nov 19, 2025 | Lloyd George W. 10b5-1 | Sell S | 47.8K | $1.8M |
| Nov 19, 2025 | Lloyd George W. 10b5-1 | Sell S | 230 | $9.0K |
| Nov 19, 2025 | Lloyd George W. 10b5-1 | Sell S | 4.6K | $179.4K |
| Nov 17, 2025 | Coyne Terrance P. KEY 10b5-1 | Sell S | 3.8K | $147.4K |
| Nov 17, 2025 | Coyne Terrance P. KEY 10b5-1 | Sell S | 65.8K | $2.6M |
| Nov 7, 2025 | Urist Marshall | Exercise C | 16.0K | $0 |
| Nov 7, 2025 | Urist Marshall | Exercise C | 160.0K | $0 |
| Nov 5, 2025 | Hite Christopher KEY | Grant A | 6.2K | $0 |
| Nov 5, 2025 | Urist Marshall | Grant A | 4.6K | $0 |
| Nov 5, 2025 | Lloyd George W. | Grant A | 6.2K | $0 |
| Nov 5, 2025 | Legorreta Pablo G. KEY | Grant A | 36.6K | $0 |
| Nov 5, 2025 | Coyne Terrance P. KEY | Grant A | 6.2K | $0 |
| Sep 30, 2025 | Bassler Bonnie L | Grant A | 1.0K | $37.5K |
| Aug 11, 2025 | Norden Gregory | Sell S | 33.5K | $1.2M |
| Aug 8, 2025 | Coyne Terrance P. KEY | Other G | 1.0K | $0 |
| Aug 8, 2025 | Urist Marshall | Other G | 3.0K | $0 |
| Aug 8, 2025 | Lloyd George W. | Other G | 8.5K | $0 |
| Aug 8, 2025 | Legorreta Pablo G. KEY | Other G | 60.0K | $0 |
| Aug 8, 2025 | Norden Gregory | Exercise C | 14.5K | $0 |
| Aug 8, 2025 | Norden Gregory | Exercise C | 144.7K | $0 |
| Aug 6, 2025 | Hite Christopher KEY | Grant A | 3.7K | $0 |
| Aug 6, 2025 | Coyne Terrance P. KEY | Grant A | 3.7K | $0 |
| Aug 6, 2025 | Urist Marshall | Grant A | 2.8K | $0 |
| Aug 6, 2025 | Lloyd George W. | Grant A | 3.7K | $0 |
| Aug 6, 2025 | Legorreta Pablo G. KEY | Grant A | 21.9K | $0 |
| Jul 31, 2025 | WEATHERMAN ELIZABETH H | Grant A | 2.8K | $0 |
| Jul 31, 2025 | WEATHERMAN ELIZABETH H | Grant A | 5.8K | $0 |
| Jul 31, 2025 | Ho Carole | Grant A | 2.8K | $0 |
| Jul 31, 2025 | Ho Carole | Grant A | 5.8K | $0 |
| Jun 30, 2025 | Bassler Bonnie L | Grant A | 1.1K | $37.5K |
| Jun 30, 2025 | Fernandez Henry A | Grant A | 1.1K | $37.5K |
About RPRX insider trading
This page tracks insider transactions for Royalty Pharma plc (RPRX) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.